Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer

Urologic Clinics of North America

Volumn 29, Issue 1, 2002, Pages 31-48

  Moyad, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ARSENIC; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RETINOL; SELENIUM; VITAMIN D;

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INHIBITION; CANCER RECURRENCE; CANCER RISK; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EXERCISE; FLUID INTAKE; GARLIC; HUMAN; PRIORITY JOURNAL; REVIEW; SOYBEAN; VEGETABLE; VITAMIN SUPPLEMENTATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARSENIC; BETA CAROTENE; DIET; DIETARY SUPPLEMENTS; EXERCISE; FEMALE; HUMANS; LIFE STYLE; MALE; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS; VITAMINS;

EID: 0036306688     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00013-7     Document Type: Review

References (224)

1. Aspirin and risk for gastric cancer: A population-based case-control study in Sweden
2. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
3. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer
4. Prevention effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial
5. Effects of dietary broccoli and butylated hydroxyanisole on liver-mediated metabolism of benzo[a]pyrene
6. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: A population-based study
7. Case-control study of bladder cancer and arsenic in drinking water
8. Tea consumption and risk of bladder and kidney cancers in a population-based case-control study
9. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
10. Effects of commonly consumed vegetables on hepatic xenobiotic-metabolizing enzymes in the mouse
11. A new method for the analysis of cohort studies: Implication of the multistage theory of carcinogenesis applied to occupational arsenic exposure
12. Occupation, smoking, and alcohol in the epidemiology of bladder cancer
13. Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington
14. Nutrient intake in relation to bladder cancer among middle-aged men and women
15. Regulation of selenoproteins
16. Comparisons of placebo, pyridoxine and topical thiotepa in preventing recurrence of stage I bladder cancer
17. Arsenic and cancer of the urinary tract
18. Bladder cancer, drinking water source, and tap water consumption: A case-control study
19. Drinking water source and chlorination by-products. I. Risk of bladder cancer
20. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. 1. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine (1954)
21. Non-steroidal anti-inflammatory drugs and bladder cancer prevention
22. Gender- and smoking- related bladder cancer risk
23. Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study
24. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water
25. Chen and Chiou respond to "Arsenic and cancer of the urinary tract" by Cantor
26. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High-arsenic artesian well water and cancers
27. Arsenic and cancers
28. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms
29. Atherogenicity and carcinogenicity of high-arsenic artesian well water: Multiple risk factors and related malignant neoplasms of blackfoot disease
30. Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8102 residents in an arseniasis-endemic area in Northeastern Taiwan
31. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan
32. Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan
33. Nutritional influence on cellular antioxidant defense systems
34. Biomathematical models for cancer: A nonmathematical view of mathematical models for cancer
35. A prospective study of diet, smoking, and lower urinary tract cancer
36. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
37. Lifestyle and occupational risk factors in cancer of the lower urinary tract
38. Lifestyle and occupational risk factors in cancer of the lower urinary tract
39. Influence of dietary fat, caloric restriction, and voluntary exercise on N-nitrosomethylurea-induced mammary tumorigenesis in rats
40. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats
41. Epidemiology and etiology of bladder cancer
42. Selenium and cancer prevention: Promising results indicate further trials required
43. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland
44. Effects of ibuprofen on the in vitro invasiveness of a human transitional cell carcinoma
45. Ingested arsenic, keratosis, and bladder cancer
46. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer
47. Allium vegetable consumption, garlic supplement intake, and female breast carcinoma incidence
48. Consumption of onions and a reduced risk of stomach carcinoma
49. A prospective cohort study on allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in the Netherlands
50. A prospective cohort study on the relationship between onion and leek consumption, garlic supplement use and the risk of colorectal carcinoma in the Netherlands
51. Association of body mass index and body fat distribution with risk of lung cancer in older women
52. Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana
53. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice
54. Selenium status and the polyp-cancer sequence: A colonoscopically controlled study
55. National primary drinking water regulations: Arsenic and clarifications to compliance and new source contaminants monitoring. Final Rule
56. Cardiovascular effects of garlic (Allium sativum): A review
57. Garlic and cancer: A critical review of the epidemiologic literature
58. Garlic consumption and cancer prevention: Meta-analyses of colorectal and stomach cancers
59. Associations between diet and cancer, ischemic heart disease, and all-cause mortality in non-Hispanic white California Seventh-day Adventists
60. Bladder cancer and drinking water: A population-based case-control study in Washington County, Maryland (United States)
61. Physical activity and cancer prevention: From observational to intervention research
62. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis
63. Promotion by ascorbic acid sodium erythrobate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine
64. Protective effect of allium vegetables against both esophageal and stomach cancer: A simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China
65. High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer
66. Prospective study of toenail selenium levels and cancer among women
67. Arsenic: Opportunity for risk assessment
68. Risk of overweight among adolescents who were breastfed as infants
69. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
70. Intake of carotenoids and retinol in relation to risk of prostate cancer
71. Relation of body size and the risk of lung cancer
72. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors
73. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
74. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49)
75. Potential interactions between alternative therapies and warfarin
76. Association between infant breastfeeding and overweight in young children
77. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer
78. Bladder cancer mortality associated with arsenic in drinking water in Argentina
79. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina
80. Tobacco use, occupation, coffee, various nutrients, and bladder cancer
81. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen disease patients and matched controls of arseniasis-hyperendemic villages
82. Multiple risk factors associated with arsenic-induced skin cancer: Effects of chronic liver disease and malnutritional status
83. Serum beta-carotene level, arsenic methylation capability and incidence of arsenic-induced skin cancer
84. Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure
85. Caloric restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice
86. The chemopreventive role of selenium in carcinogenesis
87. The Copenhagen case-control study of bladder cancer. II. Effect of coffee and other beverages
88. Prevention of bladder cancer
89. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States
90. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial
91. A case-control study of diet and prostate cancer
92. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs
93. Breast cancer and NSAID use: A meta-analysis
94. The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder
95. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada)
96. Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
97. Acetylsalicyclic acid inhibition of N-butyl-(4-hydroxybutyl) nitrosamine-induced bladder carcinogenesis in rats
98. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder
99. Leanness and lung-cancer risk
100. Relationship of dietary vitamin A and ascorbic acid intake to the risk for cancers of the lung, bladder, and prostate in Hawaii
101. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas
102. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo
103. The antiatherosclerotic effect of Allium sativum
104. Caloric restriction and experimental carcinogenesis
105. Saturated fat, vitamin C and smoking predict long-term population all-cause mortality rates in the Seven Countries Study
106. A case-control study of lung cancer among Czech women
107. Life style and occupational risk factors for bladder cancer in Germany: A case-control study
108. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland
109. Calories and cancer: Can we starve our way to health?
110. Enhanced immunocompetence by garlic: Role in bladder cancer and other malignancies
111. Megadose vitamins in bladder cancer: A double-blind clinical trial
112. Induction by inorganic metal salts of sister-chromatid exchanges and chromosome aberrations in human and in Syrian hamster cell strains
113. Superiority of intralesional immunotherapy with Corynebacterium parvum and Allium sativum in control of murine transitional cell carcinoma
114. Dietary factors in the risk of bladder cancer
115. California's reductions in smoking and bladder cancer incidence: A success story
116. The need for measures of selenium status
117. Food groups and colorectal cancer risk
118. Lack of effect of selenium on induction of tumors of esophagus and bladder in rats by two nitrosamines
119. Tea consumption: Fluid intake and bladder cancer risk in Southern Taiwan
120. Cyclooxygenase-2: A possible new target in schistosomal bladder cancer
121. Superiority of intravesical immunotherapy with Corynebacterium parvum and Allium sativum in control of murine bladder cancer
122. Obesity, cancer links prompt new recommendations
123. Case-control study of bladder cancer and water disinfection methods in Colorado
124. Tumors of the bladder: A multi-faceted problem
125. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer
126. The role of soy products in reducing risk of cancer
127. Physical activity, obesity, height, and the risk of pancreatic cancer
128. Fluid intake and the risk of bladder cancer in men
129. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort
130. Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men
131. Bladder cancer in a low risk population: Results from the Adventist Health Study
132. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer
133. Effect of soybean feeding on experimental carcinogenesis. III. Carcinogenicity of nitrite and dibutylamine in mice: A histopathological study
134. Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam
135. Epidemiologic and molecular epidemiologic methods to assess the mechanistic role of arsenic in bladder cancer causation
136. Concentration of nitrates in drinking water and its relationship with bladder cancer
137. Coffee drinking and cancer of the lower urinary tract
138. Soy, disease prevention, and prostate cancer
139. Complementary medicine for prostate cancer: Effects of soy and fat consumption
140. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression
141. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis
142. The role of obesity and diet in urological carcinogenesis
143. Bladder-cancer incidence in relation to vegetable and fruit consumption: A prospective study of atomic-bomb survivors
144. Serum selenium and the risk of cancer by specific sites: Case-control analysis of prospective data
145. Dietary factors in cancer of the lower urinary tract
146. Chemopreventive effects of nimesulide, a selective cyclooxy-genase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine
147. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment
148. The etiology of cancer of the bladder
149. Re "Vitamin A, beta-carotene, and the risk of cancer"
150. Stimulatory effect of vegetables on intestinal drug metabolism in the rat
151. Stimulatory effect of brussel sprouts and cabbage on human drug metabolism
152. Vitamin supplements and cancer risk: The epidemiologic evidence
153. Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine
154. Inhibitory effect of L-ascorbate on tumor formation in urinary bladders implanted with 3-hydro-xyanthranilic acid
155. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder
156. Relation between body mass index and lung cancer risk in men and women never and former smokers
157. Serum selenium levels in patients with malignant melanoma
158. 6) and their influence on the recurrence rate of superficial bladder cancer
159. Diet and bladder cancer in Spain: A multicenter case-control study
160. Dietary factors and the incidence of cancer of the urinary bladder
161. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder
162. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand
163. Clinical outcomes in statin treatment trials: A metaanalysis
164. Clinical applications of probiotic agents
165. Coffee consumption and bladder cancer in nonsmokers: A pooled analysis of case-control studies in European countries
166. Association between serum selenium and the risk of cancer
167. Cancer mortality correlation studies. III. Statistical associations with dietary selenium intakes
168. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore
169. Antioxidants and cancer. Part IV. Selenium and age-adjusted human cancer mortality
170. Chemoprevention by indomethacin of tumor progression in a rat urinary carcinogenesis model
171. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: A prospective study
172. Cyclooxygenase-2 expression is upregulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
173. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines
174. Fluid intake and bladder cancer in Utah
175. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water
176. Glutathione S-transferase activity: Enhancement by compounds inhibiting chemical carcinogenesis and by dietary constitutents
177. Vitamin A supplements, fried foods, fat and urothelial cancer: A case-referent study in Stockholm in 1985-87
178. Diet and bladder cancer: A meta-analysis of six dietary variables
179. Vegetables, fruit, and cancer. II. Mechanisms
180. Vegetables, fruit, and cancer prevention: A review
181. Coffee and cancer: A prospective study of 43,000 Norwegian men and women
182. Garlic for treating hypercholesterolemia: A meta-analysis of randomized clinical trials
183. Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones
184. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer
185. Serum selenium in patients with ovarian cancer during and after therapy
186. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
187. Cyclooxygenase-2 inhibitors in tumorigenesis (part II)
188. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects
189. Bladder cancer and alcoholic beverage consumption
190. The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder
191. Aspirin use and risk of fatal cancer
192. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan
193. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic
194. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan
195. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years
196. Diet in the epidemiology of bladder cancer in western New York
197. Drinking water, fluid intake, and bladder cancer in western New York
198. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: Incidence and mortality in a controlled (Finland)
199. Bladder cancer and coffee drinking: A summary of casecontrol research
200. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada
201. Allium vegetables: Their role in the prevention of cancer
202. Effect of garlic on total serum cholesterol: A meta-analysis
203. Effect of caloric restriction on age-associated cancers
204. Genes and obesity: Is there reason to change our behaviors?
205. Source of drinking water at home and site-specific cancer incidence in Washington County, Maryland
206. Diet and cancer: One view at the start of the millennium
207. Body mass index and bladder cancer risk: A preliminary report
208. Arsenic
209. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases
210. The epidemiology of bladder cancer: A second look
211. An epidemiological investigation of cancer of the bladder
212. Effects of aspirin on arylamine N-acetyltransferase activity and DNA adducts in human bladder tumour cells
213. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study
214. Alcohol consumption and bladder cancer risk: Results from the Netherlands Cohort Study
215. A major inducer of anticarcinogenic protective enzymes of broccoli: Isolation and elucidation of structure
216. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis
217. Biological response modifiers for the treatment of superficial bladder tumors